Glucocentric Drugs in Cardiovascular Disease Protection and Heart Failure
Authors
Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi
Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, University of California Los Angeles, Los Angeles, California
Section of Cardiovascular Research, Baylor College of Medicine, Houston, Texas, US; Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas
Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, US; Baylor Scott & White Research Institute, Baylor University Medical Center, Dallas, Texas
DOI: https://doi.org/10.14797/mdcvj.1155 | Journal eISSN: 1947-6108
Language: English
Page range: 40 - 53
Submitted on: Jul 14, 2022
Accepted on: Oct 31, 2022
Published on: Dec 6, 2022
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2022 Khawaja M. Talha, Gregg C. Fonarow, Salim S. Virani, Javed Butler, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.